Oral Pantoprazole for Acid Suppression in the Treatment of Patients with Zollinger-Ellison Syndrome | Zendy

Barbara Désir | Zendy; Pierre Poitras | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Oral Pantoprazole for Acid Suppression in the Treatment of Patients with Zollinger-Ellison Syndrome

Author(s) -

Barbara Désir,

Pierre Poitras

Publication year - 2001

Publication title -

canadian journal of gastroenterology

Language(s) - English

Resource type - Journals

eISSN - 1916-7237

pISSN - 0835-7900

DOI - 10.1155/2001/462456

Subject(s) - pantoprazole , zollinger ellison syndrome , medicine , gastric acid , gastrinoma , gastroenterology , omeprazole , regimen , proton pump inhibitor , basal (medicine) , stomach , gastrin , secretion , insulin

The management of patients with gastric acid hypersecretion due to gastrinoma, usually recognized as Zollinger-Ellison syndrome (ZES), was radically changed 10 years ago by the use of proton pump inhibitors. Surgical treatment now concentrates on tumour excision, and in the majority of patients, gastrectomy is no longer required to prevent complications of acid hypersecretion that can be managed pharmacologically.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research